Financing - March 3, 2026
SynAct Pharma has carried out a directed issue of new shares
Through the directed issue, the company will receive approximately SEK 51.9 million.
Biotech Business - February 24, 2026
AAX Biotech secures investment from Trio Impact Invest
The investment supports the continued development and scaling of the company’s antibody technology platforms, enabling expanded application areas and strengthened industry collaborations.
Business article - February 12, 2026
New coalition aims to strengthen Europe’s life science investment ecosystem
The European Life Sciences Coalition (ELSC) aims to strengthen Europe’s life sciences and biotechnology VC ecosystem by mobilizing greater levels of private and public investment across the sector.
Biotech Business - February 11, 2026
Neogap secures SEK 87 million to advance its personalized immunotherapy
The financing round was led by Sciety and the capital will be used to advance the company’s ongoing clinical study and to build the data required for the next stage of its development programme.
Financing - January 22, 2026
LSI Zeta has raised EUR 2.9 million
Life Science Invest’s sixth co-investment company, LSI Zeta, has raised EUR 2.9 million from 35 Nordic business angels.
Financing - November 27, 2025
Gosta Labs completes EUR 7.5 million oversubscribed seed round
The Helsinki-based healthtech company, founded by the ex-Kaiku Health founders, has closed a seed round to scale its AI operating system for complex medical specialties.
